
Chandu Gangadhar Devanpalli
About Chandu Gangadhar Devanpalli
Data last updated:
Chandu Gangadhar Devanpalli is a Director at Ardent Clinical Research Services Private Limited (since 2021) and Director at St Source Transcript Private Limited (since 2024). The companies operate in Travel and Hospitality and Software. The largest current company by reported revenue is Ardent Clinical Research Services Private Limited at ₹84 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Sep 2021 | 2021 | ₹84 Lakh (FY 2025) | Active | |
| Director | 28 Nov 2024 | 2024 | Active |
Board colleagues of Chandu Gangadhar Devanpalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Swati Dattatray Kurandale | 10781890 | Ardent Clinical Research Services Private Limited , St Source Transcript Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandu Gangadhar Devanpalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandu Gangadhar Devanpalli
Chandu Gangadhar Devanpalli currently holds 2 directorships: Ardent Clinical Research Services Private Limited (Director, since 06 Sep 2021, revenue ₹84 Lakh (FY 2025)); St Source Transcript Private Limited (Director, since 28 Nov 2024).
Chandu Gangadhar Devanpalli was first appointed on 06 Sep 2021 as Director at Ardent Clinical Research Services Private Limited. The most recent appointment on record is 28 Nov 2024 at St Source Transcript Private Limited.
The current boards of Chandu Gangadhar Devanpalli's companies include Swati Dattatray Kurandale (Ardent Clinical Research Services Private Limited).